Search Results - Thea Kalebic

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine.

    Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. by Thea Kalebic, Audrey Kinter, Guido Poli, Mary E. Anderson, A Meister, Anthony S. Fauci

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    The Insulin-like Growth Factor-I Receptor Is Required for EWS/FLI-1 Transformation of Fibroblasts

    The Insulin-like Growth Factor-I Receptor Is Required for EWS/FLI-1 Transformation of Fibroblasts by Jeffrey A. Toretsky, Thea Kalebic, Vicki Blakesley, Derek LeRoith, Lee J. Helman

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation

    Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation by Nathalie Voorzanger‐Rousselot, F. Juillet, Emmanuel Mareau, Johann Zimmermann, Thea Kalebic, Patrick Garnero

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    The Role of the Tyrosine Kinase Domain of the Insulin-like Growth Factor-I Receptor in Intracellular Signaling, Cellular Proliferation, and Tumorigenesis

    The Role of the Tyrosine Kinase Domain of the Insulin-like Growth Factor-I Receptor in Intracellular Signaling, Cellular Proliferation, and Tumorigenesis by Catalina Hernández‐Sánchez, Vicky A. Blakesley, Thea Kalebic, Lee J. Helman, Derek LeRoith

    Published 1995
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody–Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies

    Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody–Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal Malignancies by Khaldoun Almhanna, Thea Kalebic, Cristina Cruz, Jason E. Faris, David P. Ryan, JungAh Jung, Tim Wyant, Adedigbo A. Fasanmade, Wells A. Messersmith, Jordi Rodón

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies

    Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies by David C. Smith, Thea Kalebic, Jeffrey R. Infante, Lillian L. Siu, Daniel M. Sullivan, Gordana Vlahovic, John Kauh, Feng Gao, Allison Berger, Stephen Tirrell, Neeraj Gupta, Alessandra Di Bacco, Deborah Berg, Guohui Liu, Jianchang Lin, Ai-Min Hui, John A. Thompson

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: